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Abstract: 
Forward genetic screens in Drosophila melanogaster for modifiers of position-effect 
variegation have revealed the basis of much of our understanding of heterochromatin. 
We took an analogous approach to identify genes required for epigenetic repression in 
human cells. A non-lethal forward genetic screen in near-haploid KBM7 cells identified 
the Human Silencing Hub (HUSH), a complex of three poorly-characterised proteins, 
TASOR, MPP8, and periphilin, which is absent from Drosophila but conserved from 
fish to humans. We suggest that the HUSH complex is recruited to genomic loci rich in 
H3K9me3, where subsequent recruitment of the methyltransferase SETDB1 is required 
for H3K9me3 deposition and transcriptional silencing. Loss of HUSH components 
resulted in decreased H3K9me3 at endogenous genomic loci and altered transcription, 
as well as derepression of retroviruses integrated into heterochromatin.  
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Main text: 
The positioning of a normally active gene into heterochromatin can result in 
epigenetic silencing, a phenomenon known as position-effect variegation (PEV) (1). Forward 
genetic screens in the fruit fly Drosophila melanogaster for mutations that act as suppressors 
or enhancers of PEV have identified a range of key regulators of heterochromatin (2). These 
include heterochromatin protein 1 (HP1) (3) and Su(var)3-9 (4), which respectively bind and 
deposit the key repressive histone modification, tri-methylated lysine 9 of histone H3 
(H3K9me3) (5, 6). Here we set out to identify genes involved in PEV in human cells, using 
an analogous forward genetic screen in the haploid human KBM7 cell line.  
We transduced KBM7 cells with a lentiviral construct encoding a green fluorescent 
protein (GFP) fusion protein driven by the spleen focus-forming virus (SFFV) promoter (Fig. 
1A). Whilst the majority of transduced cells displayed high GFP expression, ~20% of the 
cells exhibited lower GFP expression (Fig. 1B). This was likely to be a result of reporter 
integration into a repressive chromatin environment. To identify the genes required for this 
epigenetic suppression, we isolated the population of GFPdim cells by fluorescence-activated 
cell sorting (FACS), mutagenised them with a gene-trap retrovirus, and enriched for rare 
mutant GFPbright cells via two rounds of FACS (Fig. 1C). Mapping the gene-trap integration 
sites among the GFPbright cells identified several genes that were significantly enriched for 
inactivating insertions compared to an unselected control population, including SETDB1, 
FAM208A, MPHOSPH8 (encoding M-phase phosphoprotein 8, MPP8) and PPHLN1 
(encoding periphilin) (Fig. 1D and fig. S1A). The uncharacterised gene FAM208A was 
renamed TASOR (Transgene Activation Suppressor). 
We validated the role of these four genes by short-hairpin RNA (shRNA)-mediated 
knockdown in KBM7 cells (fig. S1, B and C), and using an independent GFP reporter 
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construct in HeLa cells (Fig. 1E and fig. S2). This effect was not limited to retroviral 
constructs, as stably integrated reporter constructs delivered by transfection were similarly 
repressed (Fig. 1F and fig. S3), and was apparent using both viral and cellular promoters (fig. 
S4). The variable proportion of GFPdim cells observed with different reporter constructs, 
however, did suggest that the DNA sequence of the reporter may influence the degree of 
silencing. Thus, repression by these four genes appeared to be predominantly governed by the 
genomic landscape surrounding the transgene integration site, but could also be modulated by 
the sequence composition of the reporter. 
To determine whether these genes act as part of a multi-protein complex, we analysed 
TASOR immunoprecipitates from KBM7 nuclei by mass spectrometry. After discounting 
proteins also present in control immunoprecipitates, two putative interacting proteins 
remained: MPP8 and periphilin (table S1 and fig. S5A), the same proteins identified by our 
genetic screen (Fig. 1D). Thus, both genetic and proteomic approaches converged on a 
repressive complex comprising TASOR, MPP8 and periphilin, which we named the Human 
Silencing Hub (HUSH) complex (fig. S5B). TASOR, MPP8 and periphilin all localised to the 
nucleus (fig. S5, C and D). Interactions between HUSH complex members were readily 
confirmed by co-immunoprecipitation experiments (Fig. 1G), and knockdown of each of the 
three proteins resulted in decreased levels of the other HUSH complex subunits (fig. S5, E 
and F). This was not the case upon knockdown of SETDB1 (fig. S5G), which did not appear 
to be a constitutive member of the HUSH complex.  
As the leading hit in the genetic screen was the H3K9 methyltransferase SETDB1 (7), 
and the chromodomain of MPP8 binds H3K9me3 (8–10), our investigation into the 
mechanism of repression by the HUSH complex focussed on the repressive H3K9me3 
histone mark. High levels of H3K9me3 were found on repressed, GFPdim reporters, but not on 
active, GFPbright reporters (Fig. 2A and fig. S6). Consistent with a role for the HUSH complex 
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in facilitating the deposition of H3K9me3, depletion of HUSH subunits resulted in a decrease 
in H3K9me3 across the reporter (Fig. 2B), concomitant with an increase in GFP mRNA 
expression (Fig. 2C). Furthermore, HUSH subunits were chromatin-associated (Fig. 2D), and 
we detected binding of epitope-tagged HUSH subunits to a repressed reporter (Fig. 2E). 
HUSH subunits co-immunoprecipitated with SETDB1 (Fig. 2F), and knockdown of HUSH 
complex members impaired the recruitment of SETDB1 to a repressed GFP reporter (Fig. 
2G). Thus, the HUSH complex appeared to facilitate the deposition of the repressive 
H3K9me3 histone modification through the targeted recruitment of SETDB1. 
HUSH repressed almost all GFPdim reporter integrations (Fig. 3A and fig. S7). Thus, 
by comparing the integration sites of the GFP reporter in the GFPdim versus the GFPbright 
populations, we could determine where HUSH acted in the genome (Fig. 3B). GFPdim 
integrations were most enriched in proximity to H3K9me3, and underrepresented in 
proximity to histone marks correlated with active chromatin (Fig. 3C and fig. S8A). We also 
compared genes which were highly enriched for GFPdim insertions over GFPbright insertions 
(“dim genes”) or vice versa (“bright genes”). H3K9me3 levels across “dim genes” were much 
higher than across “bright genes” (Fig. 3D and fig. S8B). The majority of the leading “dim 
genes” were KRAB-ZNF genes (fig. S8, C to E), which are covered with high levels of 
H3K9me3 (11), deposited by SETDB1 (12). To validate these observations directly, we used 
the CRISPR/Cas9 system to integrate a non-retroviral GFP reporter construct at an example 
KRAB-ZNF gene (Fig. 3E). This construct was indeed subject to HUSH-mediated repression 
(Fig. 3F and fig. S9). Thus, the HUSH complex preferentially silenced transgenes integrating 
into chromatin marked by high levels of H3K9me3. 
Recruitment of the HUSH complex to loci rich in H3K9me3 could be mediated 
through the chromodomain of MPP8 (8–10). An H3 peptide trimethylated at K9, but not an 
unmodified H3 peptide, pulled-down MPP8 together with TASOR from a nuclear lysate (fig. 
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S10A). TASOR recruitment to H3K9me3 was dependent on MPP8, and was lost following 
MPP8 depletion (fig. S10A). Additionally, the purified chromodomain of MPP8 has been 
shown to bind chromatin marked by high levels of H3K9me3 (fig. S10B) (13), and we 
detected binding of epitope-tagged HUSH subunits to genes rich in H3K9me3 (fig. S10C). 
To determine whether the chromodomain of MPP8 was essential for re-establishment of 
reporter repression, we generated a HUSH triple knockout reporter clone lacking expression 
of TASOR, MPP8 and periphilin using CRISPR/Cas9 technology (fig. S11). Re-expression 
of wild-type HUSH subunits resulted in re-repression of the reporter, but this was severely 
abrogated upon reconstitution with an MPP8 chromodomain mutant (W80A) that cannot bind 
H3K9me3 (8) (Fig. 3G and fig. S12A). In contrast, in cells lacking MPP8 alone, a functional 
chromodomain was not absolutely critical for re-repression of the reporter, as the W80A 
MPP8 mutant could partially restore reporter repression (fig. S12, B and C). This result 
suggested that another member of the HUSH complex must also contribute to HUSH 
localisation at target sites. Indeed we found that, in the absence of either TASOR or MPP8, 
periphilin was still able to localise to chromatin (fig. S12, D and E). Thus, the chromodomain 
of MPP8 was required for the initial targeting of the HUSH complex to H3K9me3-marked 
loci, but periphilin also contributed to the maintenance of the complex at chromatin.  
Given that the HUSH complex regulates H3K9me3 levels across integrated reporter 
constructs, we asked whether it maintains H3K9me3 at endogenous genomic loci. ChIP 
followed by deep sequencing (ChIP-seq) in CRISPR/Cas9-generated TASOR, MPP8, 
periphilin and SETDB1 knockout HeLa cells (fig. S11) identified 918 shared genomic loci 
(14) with markedly reduced levels of H3K9me3 upon loss of HUSH subunits (Fig. 4A and 
table S2). Furthermore, knockout of SETDB1 resulted in a decrease in H3K9me3 at 916/918 
(99.6%) of the shared loci affected by loss of HUSH, with the majority (91%) showing a >3-
fold reduction (Fig. 4B). This confirmed a functional association between this critical 
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methyltransferase and the HUSH complex. At four example loci, the decrease in H3K9me3 
levels as a result of loss of HUSH or SETDB1 (Fig. 4C) resulted in modest increases in gene 
expression (Fig. 4D). 
Retroviral integration into heterochromatin is a natural mimic of position effect 
variegation. As such we reasoned that viruses – and not merely transgenes delivered in the 
context of self-inactivating (SIN) vectors – might also be subject to HUSH-mediated 
repression. We infected the CD4+ lymphoid cell line Jurkat with a standard HIV-1 reporter 
virus which contains the wild-type HIV-1 LTR promoter driving both the HIV-1 
transactivator Tat and GFP (HIV-1 LTR-Tat-IRES-GFP) (15) (Fig. 4E). Again we observed a 
range of GFP expression levels (Fig. 4F). The repressed proviruses in the GFPdim cells were 
subject to HUSH-mediated repression, because knockdown of HUSH subunits resulted in 
transcriptional activation (Fig. 4G) accompanied by a decrease in H3K9me3 levels (Fig. 4H). 
Depletion of HUSH subunits also resulted in derepression of silent HIV-1 reporter proviruses 
in J-Lat clones (fig. S13), a widely used cellular model of HIV-1 silencing (15, 16), and 
similarly in an analogous “K-Lat” model that we generated in KBM7 cells (fig. S14). This 
effect was not limited to the HIV-1 LTR; we also found HUSH acted upon repressed murine 
leukaemia virus (MLV) integrations (fig. S15). Thus the HUSH complex mediates epigenetic 
regulation of both endogenous and viral genes at heterochromatic loci marked by H3K9me3. 
By replicating a classic Drosophila forward genetic screen for modifiers of PEV in 
cultured human cells, we identified the HUSH complex. HUSH mediated epigenetic 
repression through the recruitment of SETDB1 and the deposition of H3K9me3. Surprisingly 
we did not identify a role for canonical heterochromatin regulators required for PEV in 
Drosophila, such as HP1 (fig. S16) (17). HUSH complex subunits are absent from 
Drosophila but conserved from fish to humans, suggesting an additional, more recently 
acquired route to H3K9me3-mediated heterochromatin regulation in mammalian cells. 
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Figure Captions: 
 
Fig. 1. A haploid genetic screen identifies a requirement for the HUSH complex for 
epigenetic repression in human cells. 
(A) Schematic view of the GFP reporter construct (see (14) for further details). (B) 
Transduction of KBM7 cells with the GFP reporter results in a majority GFPbright population 
plus a repressed GFPdim population. (C) A haploid genetic screen to identify genes required 
for repression of the GFP reporter. (D) Bubble plot illustrating the hits from the screen. 
Bubble size is proportional to the number of independent inactivating gene-trap integrations 
identified (shown in brackets). (E and F) Validation of the screen hits in HeLa cells, using an 
independent lentiviral reporter (E) and a non-viral reporter containing the phosphoglycerate 
kinase 1 (PGK) promoter driving GFP delivered by transfection (F). Histograms were gated 
on GFP+ cells. (G) TASOR, MPP8 and periphilin form a complex. Endogenous TASOR, 
MPP8 and periphilin were immunoprecipitated from KBM7 cells, and the indicated co-
immunoprecipitating proteins identified by immunoblot. We were unable to blot for 
periphilin as the antibody does not recognise its epitope following NP-40 lysis. 
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Fig. 2. The HUSH complex functions through H3K9me3 via the targeted recruitment of 
SETDB1.  
(A) GFPdim integrations are marked by H3K9me3 but not H3K27me3. H3K9me3 and 
H3K27me3 levels across the reporter were assessed by ChIP-qPCR in sorted GFPdim and 
GFPbright populations. (B and C) Knockdown of HUSH components results in a loss of 
H3K9me3 across a GFPdim reporter as assessed by ChIP-qPCR (B), concomitant with an 
increase in GFP transcript levels (C). (D) Subcellular fractionation showing that HUSH 
subunits are found in the chromatin fraction. GAPDH, Rb and HP1α were used to validate the 
fractionation. (E) V5-tagged HUSH subunits bind to a repressed GFP reporter as assessed by 
ChIP-qPCR. (F) Co-immunoprecipitation of TASOR and MPP8 with SETDB1. (G) 
Knockdown of HUSH components results in impaired recruitment of SETDB1 to a GFPdim 
reporter, as assessed by ChIP-qPCR.  
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Fig. 3. The HUSH complex functions at genomic loci rich in H3K9me3. 
(A) HUSH represses the majority of GFPdim reporter integrations. Populations of GFPdim and 
GFPbright cells were isolated by FACS and subjected to knockdown of TASOR. (B to D) The 
HUSH complex acts at genomic loci marked by high levels of H3K9me3. Reporter 
integration sites were mapped among the GFPdim and GFPbright populations (B). Correlating 
integration sites with ENCODE ChIP-seq peaks for K562 cells showed that GFPdim 
integration sites were most enriched in proximity to H3K9me3 (C). Examples of the top “dim 
genes” and “bright genes” are shown in (D). (E and F) HUSH-mediated repression of a GFP 
reporter construct targeted to ZNF594. (G) Re-establishment of reporter repression upon 
reconstitution of a HUSH triple knockout clone.  
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Fig. 4. The HUSH complex maintains H3K9me3 at endogenous loci and represses 
viruses integrated into heterochromatin. 
(A to C) Loss of HUSH results in decreased H3K9me3 at endogenous genomic loci. Global 
levels of H3K9me3 were measured by ChIP-seq in wild-type HeLa cells and cells lacking 
HUSH subunits and SETDB1. The CRISPR/Cas9-mediated disruption of TASOR, MPP8 and 
periphilin resulted in decreased H3K9me3 at shared loci (A). Knockout of SETDB1 resulted 
in decreased H3K9me3 at over 99% of these loci, with the majority (91%) showing a >3-fold 
reduction (B). Four example loci are shown in (C). (D) Loss of HUSH resulted in increased 
expression of the four example genes from (C), as measured by qRT-PCR. (E to H) Proviral 
repression by the HUSH complex. Schematic view of the HIV-1 LTR-Tat-IRES-GFP virus 
(E). Infection of Jurkat cells resulted in a range of GFP expression levels (F); the proviruses 
in the GFPdim cells were repressed by the HUSH complex (G) through H3K9me3 (H). TNF-α 
activates transcription from the HIV-1 LTR through the NF-κB pathway (18). 
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>3-fold reduction in H3K9me3
upon SETDB1 knockout
